Atlantic International Corp.
NASDAQ:ATLNMedical - Diagnostics & Research
-$0.10 today
- Market cap
- $73.17M
- Beta
- 0.71
- P/E (TTM)
- -0.6
- EPS (TTM)
- -$1.08
Volume 18.56M
Average 0.44M
ATLN Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Atlantic International Corp.NASDAQ: ATLN
Accounts Payables · Q4 FY2025 · quarter ended Dec 2025
Accounts payables turns negative
Q4 FY2025 accounts payables was -$188.2K, compared with $643.12K a year earlier. Trailing-twelve-month accounts payables was $941.09K.
Context
- Accounts payables amounted to 0.7% of revenue in FY2025, up 0.4 pp from a year earlier.
- Accounts payables increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts payables holds near -$188.2K or moves back toward the trailing-twelve-month quarterly average of $235.27K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 3.08M USD
- Year-over-year change
- +150.9%
- 4-year CAGR
- +324.1%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.08M | +150.9% |
| FY2024 | 2024-12-31 | 1.23M | +94.4% |
| FY2023 | 2023-12-31 | 631.86K | +353.8% |
| FY2022 | 2022-12-31 | (248.93K) | -2713.7% |
| FY2021 | 2021-12-31 | 9.52K | — |
Accounts Payables vs competitors
How ATLN compares with its peers on the latest reported figures
- ATLN's LTM Dec 2025 accounts payables of $941.09K is the 6th largest of the 8 companies compared; the peer median is $887K.
- Its year-over-year change of -23.4% is the 5th highest of 7, against a peer median of +42.9%.
- Accounts payables amounts to 0.2% of revenue for ATLN, versus a peer median of 17.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $7.58M | +55.9% | — | 425.1% | |
| LTM Mar 2026 | $3.73M | — | — | 3.3% | |
| LTM Mar 2026 | $2.06M | -230.7% | -12.7% | — | |
| LTM Mar 2026 | $1.6M | +29.9% | -3.7% | — | |
| LTM Mar 2026 | $1.45M | +154.8% | -3.8% | 1.0% | |
ATLNAtlantic International Corp. | LTM Dec 2025 | $941.09K | -23.4% | — | 0.2% |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $887K | +2749.0% | — | 47.9% |
IMDXInsight Molecular Diagnostics Inc. | LTM Mar 2026 | $337K | -70.4% | +107.3% | 17.3% |
| Peer median (excluding ATLN) | $887K | +42.9% | -3.8% | 17.3% | |
Competitors are the stored peer set for ATLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (3.7M) | (4.09M) | (15.25M) | (135.48M) | (59.43M) |
| Depreciation & Amortization | 86.44K | 87.94K | 5.04M | 4.99M | 210.5K |
| Deferred Income Tax | 0 | 0 | (5.14M) | 5.24M | 0 |
| Stock-Based Compensation | 333.98K | 256.9K | 0 | 45.2M | 36.14M |
| Change in Working Capital | 119.96K | (155.38K) | 204.34K | 15.95M | 10.22M |
| Accounts Receivables | 73.85K | (15.54K) | (384.28K) | (9.92M) | 2.41M |
| Inventory | (21.14K) | (20.71K) | 0 | 0 | 0 |
| Accounts Payables | 9.52K | (248.93K) | 631.86K | 1.23M | 3.08M |
| Other Working Capital | 57.73K | 129.79K | (43.24K) | 24.64M | 4.72M |
| Other Non-Cash Items | 1.17M | 242.81K | 6.07M | 58.11M | 8.47M |
| Operating Cash Flow | (1.99M) | (3.66M) | (9.08M) | (5.99M) | (4.4M) |
| Capital Expenditures | (14.47K) | (40.02K) | (73.71K) | (73.46K) | (66.77K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (5.98M) | (4.01M) | (2.8M) | 0 | 0 |
| Sales of Investments | 0 | 5.88M | 6.92M | 0 | 0 |
| Other Investing Activities | 0 | 0 | (4.12M) | 0 | 0 |
| Investing Cash Flow | (5.99M) | 1.83M | (73.71K) | (73.46K) | (66.77K) |
| Debt Repayment | (187.89K) | 0 | 8.83M | (962.48K) | 3.87M |
| Common Stock Issued | 13.81M | 0 | 1.8M | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.63M) | 0 | (1.84M) | 6.35M | 0 |
| Financing Cash Flow | 12M | 0 | 8.79M | 5.38M | 3.87M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 4.02M | (1.83M) | (363.23K) | (674.25K) | (597.54K) |
| Free Cash Flow | (2M) | (3.7M) | (9.16M) | (6.06M) | (4.46M) |
Atlantic International Corp.
NASDAQ:ATLN
Intrinsic Alpha fair value
Locked
Current Price
$0.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.